수행 실적
Experience
Clinical Development / Post Approval Stages
| Type | 비율 | 비율 막대 |
|---|---|---|
| Medical Device | 23% | |
| Others | 14% | |
| Phase 1 | 13% | |
| Phase 2 | 12% | |
| Phase 3 | 12% | |
| OS | 7% | |
| IIT | 7% | |
| PMS | 5% | |
| HFF & Cosmetic | 4% | |
| Phase 4 | 3% |
| Therapeutic Area | 비율 | 비율 막대 |
|---|---|---|
| Dermatology | 16% | |
| Endocrinology | 15% | |
| Cardiology | 12% | |
| Gastroenterology | 10% | |
| Others | 7% | |
| Pulmonology | 6% | |
| Ophthalmology | 5% | |
| Neurology | 4% | |
| E.N.T | 4% | |
| Orthopedics | 3% | |
| Hepatology | 3% | |
| Hematology | 2% | |
| Oncology | 2% | |
| Urology | 2% | |
| Plastic Surgery | 1% | |
| Dentistry | 1% |
Experience
Phase 1 (Including Bioequivalence Study)
- 80%동등률
- 177건수행 건수
- 140건동등 건수
| Therapeutic Area | 비율 | 비율 막대 |
|---|---|---|
| Endocrinology | 22% | |
| Cardiovascular | 21% | |
| Hematology | 14% | |
| Gastroenterology | 12% | |
| Pain Killer | 11% | |
| Nervous System | 8% | |
| Immunology | 5% | |
| Antibiotics | 2% | |
| Infectious Disease | 2% | |
| Urology | 2% | |
| Ophthalmology | 1% |